Back to Search
ASHLEY STRACK, PHARMD
PHARMD
Pharmacist
NPI: 1689551269Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
073013(NY)
Research & Publications (20)
Regulation of the kinetics of intracerebral chemokine gene expression in murine Toxoplasma encephalitis: impact of host genetic factors.
PMID 12420316·Glia·2002
4-observational
Chemokines are differentially expressed by astrocytes, microglia and inflammatory leukocytes in Toxoplasma encephalitis and critically regulated by interferon-gamma.
PMID 11935261·Acta Neuropathol·2002
7-preclinical
Concerted action of two novel auxiliary proteins in assembly of the active site in a membrane-bound [NiFe] hydrogenase.
PMID 19017638·J Biol Chem·2009
8-other
1-Sulfonyl-4-acylpiperazines as selective cannabinoid-1 receptor (CB1R) inverse agonists for the treatment of obesity.
PMID 19320488·J Med Chem·2009
7-preclinical
Lack of protection with a novel, selective melanocortin receptor subtype-4 agonist RY767 in a rat transient middle cerebral artery occlusion stroke model.
PMID 19052481·Pharmacology·2009
4-observational
Pyridopyrimidine based cannabinoid-1 receptor inverse agonists: Synthesis and biological evaluation.
PMID 19328684·Bioorg Med Chem Lett·2009
7-preclinical
Discovery of imidazole carboxamides as potent and selective CCK1R agonists.
PMID 18614364·Bioorg Med Chem Lett·2008
7-preclinical
2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity.
PMID 18684621·Bioorg Med Chem Lett·2008
4-observational
The triple uptake inhibitor (1R,5S)-(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV 21947) reduces body weight and plasma triglycerides in rodent models of diet-induced obesity.
PMID 18089843·J Pharmacol Exp Ther·2008
4-observational
Characterization of a novel and selective cannabinoid CB1 receptor inverse agonist, Imidazole 24b, in rodents.
PMID 18021763·Eur J Pharmacol·2008
4-observational
Substituted acyclic sulfonamides as human cannabinoid-1 receptor inverse agonists.
PMID 17293109·Bioorg Med Chem Lett·2007
7-preclinical
Antiobesity efficacy of a novel cannabinoid-1 receptor inverse agonist, N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide (MK-0364), in rodents.
PMID 17327489·J Pharmacol Exp Ther·2007
7-preclinical
Expression pattern and cellular sources of chemokines in primary central nervous system lymphoma.
PMID 17641901·Acta Neuropathol·2007
8-other
Lead optimization of 5,6-diarylpyridines as CB1 receptor inverse agonists.
PMID 17270441·Bioorg Med Chem Lett·2007
7-preclinical
Design and synthesis of (ant)-agonists that alter appetite and adiposity.
PMID 16876570·Prog Brain Res·2006
6-review
2-Aminoquinoline melanin-concentrating hormone (MCH)1R antagonists.
PMID 16919456·Bioorg Med Chem Lett·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 25 WINSLOW GATE RD
POUGHKEEPSIE, NY 12601 - Phone
- (845) 224-0495
Quick Facts
- NPI
- 1689551269
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile